-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IPED-2015 in Depression
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.IPED-2015 in DepressionDrug Details:IPED-2015 is under development for the treatment of organic erectile dysfunction, depression and neuropathic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – IPED-2015 in Neuropathic Pain (Neuralgia)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.IPED-2015 in Neuropathic Pain (Neuralgia) Drug Details:IPED-2015 is under development for the treatment of organic erectile...
-
Product Insights
![]()
United Kingdom (UK) Protection Insurance – Income Protection Market
United Kingdom (UK) Protection Insurance – Income Protection Market Report Overview The income protection (IP) market experienced strong growth in 2022. Contracts increased to 213,100, while premiums generated from these contracts was GBP81 million in 2022. The number of IP contracts is expected to witness a surge during the projected period as consumers gain confidence due to minimizing inflation, falling interest rates, and the improving economy. This will further result in the IP premiums growing at a CAGR of more...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pudafensine in Depression
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pudafensine in Depression Drug Details: Pudafensine (IPED-2015) is under development for the treatment of organic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pudafensine in Neuropathic Pain (Neuralgia)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pudafensine in Neuropathic Pain (Neuralgia) Drug Details: Pudafensine (IPED-2015) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EB-06 in Vitiligo
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.EB-06 in VitiligoDrug Details:NI-0801 is under development for the treatment of acute lung injury and vitiligo....
-
Sector Analysis
New![]()
Peru Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2027
The construction industry in Peru is projected to shrink by 5.1% in real terms this year, following an annual growth of 3% in 2022. Political instability along with economic challenges, including elevated inflation and construction costs and high interest rates, will dampen investment activity. According to the Instituto Nacional de EstadÃstica e Informática (INEI), the average construction material price index remained high, rising by 1.2% year on year (YoY) in the first nine months of 2023 having jumped 11.5% in...
-
Product Insights
![]()
IP Australia – Woden Headquarters Upgrade – Australian Capital Territory
Equip yourself with the essential tools needed to make informed and profitable decisions with our IP Australia - Woden Headquarters Upgrade - Australian Capital Territory report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
Great Stone IP – Minsk Amusement Park Development – Minsk
Equip yourself with the essential tools needed to make informed and profitable decisions with our Great Stone IP - Minsk Amusement Park Development - Minsk report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
![]()
IPE Harlow/ Terminus House – Terminus Street Residential Complex – Essex
Equip yourself with the essential tools needed to make informed and profitable decisions with our IPE Harlow/ Terminus House - Terminus Street Residential Complex - Essex report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
Ideal Property – IP Bayan Lepas Mixed-Use Development – Penang
Equip yourself with the essential tools needed to make informed and profitable decisions with our Ideal Property - IP Bayan Lepas Mixed-Use Development - Penang report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Neuron Stem Cells (Insc) in Ischemic Stroke
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Neuron Stem Cells (Insc) in Ischemic StrokeDrug Details:Stem cell therapy is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Neuron Stem Cells (Insc) in Parkinson’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Neuron Stem Cells (Insc) in Parkinson's DiseaseDrug Details:Stem cell therapy is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PEP-010 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-010 in Solid Tumor Drug Details: PEP-010 (DPTC-9h) is under development for the treatment...
-
Track & Monitor
![]()
Artificial Intelligence in Retail: In-store product recognition
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the Retail industry’s In-store product recognition area within Artificial Intelligence theme. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with...
-
Product Insights
![]()
Cipriani/ Kylin Int/ Plaza Ip – Blackwood Pointe Mixed-Use Development – East Grand Bahama
Equip yourself with the essential tools needed to make informed and profitable decisions with our Cipriani/ Kylin Int/ Plaza Ip - Blackwood Pointe Mixed-Use Development - East Grand Bahama report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
![]()
Inter Pipeline/ Itochu/ Petronas – Petronas/Itochu/IP Blue Ammonia and Blue Methanol Plant – Alberta
Equip yourself with the essential tools needed to make informed and profitable decisions with our Inter Pipeline/ Itochu/ Petronas - Petronas/Itochu/IP Blue Ammonia and Blue Methanol Plant - Alberta report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
![]()
BBCA Group/ MFB Zrt/ Szolnok IP – Szolnok Citric Acid Plant – Jasz-Nagykun-Szolnok
Equip yourself with the essential tools needed to make informed and profitable decisions with our BBCA Group/ MFB Zrt/ Szolnok IP - Szolnok Citric Acid Plant - Jasz-Nagykun-Szolnok report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Track & Monitor
![]()
Artificial intelligence in banking: automated collateral validation
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the banking industry’s automated collateral validation within Artificial intelligence innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep...
-
Track & Monitor
![]()
Innovation in banking: cashless settlement
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the banking industry’s cashless settlement innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience in...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.